A 2021 update : approach to asthma management in adults

dc.contributor.authorSchellack, Natalie
dc.contributor.authorTruter, A.
dc.contributor.authorNtuli, P.N.
dc.contributor.authorMokwele, N.
dc.contributor.authorMogale, K.
dc.contributor.authorEsterhuizen, A.
dc.date.accessioned2022-07-29T06:47:57Z
dc.date.available2022-07-29T06:47:57Z
dc.date.issued2021-08
dc.description.abstractAsthma is a chronic inflammatory disease that causes hyper-responsiveness of the bronchial tree, with reversible airflow obstruction. The condition places a significant burden on our healthcare system. Chronic asthma can cause remodelling of the airway. Patients suffering from asthma should be aware of the signs and symptoms thereof, as well as the factors that can precipitate an asthmatic attack. Asthma is mostly classified as either acute or chronic; the diagnosis of asthma is based on identifying both a characteristic pattern of respiratory symptoms and variable expiratory airflow limitation. Treatment is based on how the patient presents and includes bronchodilators, inhaled corticosteroids and mast cell stabilisers. This article provides an overview of the diagnosis, characterisation and treatment of asthma.en_US
dc.description.departmentPharmacologyen_US
dc.description.urihttp://www.sapj.co.zaen_US
dc.identifier.citationSchellack, N., Truter, A., Ntuli, P. N. et al. 2021, 'A 2021 update : approach to asthma management in adults', SA Pharmaceutical Journal, vol. 88, no. 4, pp. 17-24, doi : 10.520/ejc-mp_sapj_v88_n4_a6.en_US
dc.identifier.issn2220-1017 (online)
dc.identifier.issn2221-5875 (print)
dc.identifier.other10.520/ejc-mp_sapj_v88_n4_a6
dc.identifier.urihttps://repository.up.ac.za/handle/2263/86581
dc.language.isoenen_US
dc.publisherMedpharm Publicationsen_US
dc.rightsMedpharm Publications. This article is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.5 South Africa License.en_US
dc.subjectAsthmaen_US
dc.subjectBronchodilatoren_US
dc.subjectInhaled corticosteroiden_US
dc.subjectβ-agonisten_US
dc.subjectSpirometryen_US
dc.subjectPeak expiratory flowen_US
dc.subjectShort-acting β2-agonist (SABA)en_US
dc.subjectLong-acting β2-agonist (LABA)en_US
dc.titleA 2021 update : approach to asthma management in adultsen_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Schellack_Update_2021.pdf
Size:
212.49 KB
Format:
Adobe Portable Document Format
Description:
Article

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.75 KB
Format:
Item-specific license agreed upon to submission
Description: